Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using its DehydraTECH technology in Delivering Antiviral Drugs

Stock Information for Lexaria Bioscience Corp

Loading

Please wait while we load your information from QuoteMedia.